Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TT-00920 / TransThera Biosci
NCT04364789: Phase I, First-In-Human Study of TT-00920 in Healthy Subjects	Completed	1	42	US	TT-00920, Placebos	TransThera Sciences (Nanjing), Inc.	Healthy	06/21	03/22
NCT05043792: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects	Completed	1	20	US	TT-00920, TT-00920 Placebo	TransThera Sciences (Nanjing), Inc.	Healthy	11/21	11/21
NCT05355129: A Phase 1 Study of TT-00920 in Healthy Subjects	Completed	1	30	RoW	TT-00920, TT-00920 Placebo	TransThera Sciences (Nanjing), Inc.	Healthy	06/22	06/22